Publications by authors named "Andreas Cerny"

67Publications

Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.

J Autoimmun 2020 Nov 20:102578. Epub 2020 Nov 20.

Paediatric Liver, GI and Nutrition Centre, MowatLabs, King's College London Faculty of Life Sciences & Medicine at King's College Hospital, Denmark Hill, London, SE5 9RS, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2020.102578DOI Listing
November 2020

The complement system in liver diseases: Evidence-based approach and therapeutic options.

J Transl Autoimmun 2019 Dec 18;2:100017. Epub 2019 Sep 18.

Labormedizinisches Zentrum Dr. Risch, Waldeggstrasse 37, CH-3097, Liebefeld bei Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtauto.2019.100017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388403PMC
December 2019

Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.

Clin Res Hepatol Gastroenterol 2020 11 10;44(6):e141-e144. Epub 2020 Jun 10.

Division of Infectious Diseases, Ente Ospedaliero Cantonale, Ospedale Civico and Ospedale Italiano, Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2020.05.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284277PMC
November 2020

Nonalcoholic fatty liver disease burden - Switzerland 2018-2030.

Swiss Med Wkly 2019 Dec 17;149:w20152. Epub 2019 Dec 17.

Center for Disease Analysis, Lafayette, Colorado, USA 0017208903817 | 0017204423453.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2019.20152DOI Listing
December 2019

Neurologic complications of acute hepatitis E virus infection.

Neurol Neuroimmunol Neuroinflamm 2020 01 5;7(1). Epub 2019 Dec 5.

From the Department of Neurology (P.R., G.M., C.S., C.Z., G.D., A.K.-L., C.G.), Neurocenter of Southern Switzerland, Lugano, CH; Laboratory of Microbiology EOLAB (E.P., G.M.), Bellinzona, CH; Faculty of Biomedical Sciences, USI (G.M., C.Z., A.K.-L., C.G.), Lugano, CH; Division of Gastroenterology and Hepatology, Lausanne University Hospital (M.F., D.M.), Lausanne, CH; Institute of Microbiology, Lausanne University Hospital (R.S.), Lausanne, CH; Laboratory of Immunology, Lausanne University Hospital (V.A.), CH; Department of Hepatology, Hospital of Bellinzona (F.B.), CH; Division of Infectious Diseases (E.B.), Hospital of Lugano, CH; Epatocentro Ticino (B.T.B.-P., A.C.), Lugano, CH; Queens Park (H.R.D.), London, UK; Synlab Ticino (C.Z.), Bioggio, CH; and Unilabs Ticino (B.M.), Lugano, CH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935854PMC
January 2020

Sleep stage classification from heart-rate variability using long short-term memory neural networks.

Sci Rep 2019 Oct 2;9(1):14149. Epub 2019 Oct 2.

Royal Philips, Research, High Tech Campus 34, 5656 AE, Eindhoven, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-49703-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775145PMC
October 2019

Controlling HCV in Switzerland: running against the clock.

Swiss Med Wkly 2019 03 24;149:w20005. Epub 2019 Mar 24.

Epatocentro Ticino, Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2019.20005DOI Listing
March 2019

Hepatitis.

Authors:
Andreas Cerny

Ther Umsch 2017 Jul;74(3):77

1 Epatocentro Ticino, Lugano.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000888DOI Listing
July 2017

A systematic review and meta-analysis of HCV clearance.

Liver Int 2017 10 30;37(10):1431-1445. Epub 2017 Mar 30.

Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13401DOI Listing
October 2017

Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!

Authors:
Andreas Cerny

Swiss Med Wkly 2015 23;145:w14231. Epub 2015 Dec 23.

Epatocentro Ticino, Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2015.14231DOI Listing
September 2016

[Update Chronic Viral Hepatitis B and C].

Praxis (Bern 1994) 2015 Dec;104(25):1393-7

1 Epatocentro Ticino, Lugano.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a002207DOI Listing
December 2015

Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland.

Cancer Epidemiol 2014 Dec 17;38(6):679-85. Epub 2014 Oct 17.

Ticino Cancer Registry, Institute of Pathology, 6600 Locarno, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2014.09.008DOI Listing
December 2014

Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection.

Swiss Med Wkly 2013 17;143:w13793. Epub 2013 May 17.

Federal Office of Public Health (FOPH), Division of Communicable Diseases, Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2013.13793DOI Listing
December 2013

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

J Exp Med 2013 Jun 27;210(6):1109-16. Epub 2013 May 27.

Infectious Diseases Service, Department of Medicine and Hepatology, University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20130012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674704PMC
June 2013

[Management of the cirrhotic patient].

Ther Umsch 2011 Apr;68(4):207-11

Dipartimento di Medicina Interna, Ospedale Regionale Bellinzona e Valli, Bellinzona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000152DOI Listing
April 2011

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.

J Hepatol 2011 Sep 12;55(3):529-535. Epub 2011 Jan 12.

Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Switzerland; Institute of Microbiology, University Hospital and University of Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2010.12.020DOI Listing
September 2011

Granulomatous hepatitis after intravesical bacillus Calmette-Guérin treatment.

Scand J Infect Dis 2011 Jan 21;43(1):55-7. Epub 2010 Sep 21.

Dipartimento di Medicina Interna, Ospedale Regionale di Lugano, Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365548.2010.515609DOI Listing
January 2011

Liposome-based vaccines.

Methods Mol Biol 2010 ;605:163-75

Institute of Molecular Cancer Research, University of Zürich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-60327-360-2_11
Publisher Site
http://dx.doi.org/10.1007/978-1-60327-360-2_11DOI Listing
April 2010

Hepatitis C after simultaneous liver-kidney transplantation.

Authors:
Andreas Cerny

J Hepatol 2009 Nov 18;51(5):839-41. Epub 2009 Aug 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2009.08.002DOI Listing
November 2009

Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance.

J Virol 2008 Mar 9;82(6):3147-53. Epub 2008 Jan 9.

Massachusetts General Hospital and Harvard Medical School, Partners AIDS Research Center, MGH East no. 5239, 149 13th St., Charlestown, MA 02143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02252-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258967PMC
March 2008

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.

Clin Gastroenterol Hepatol 2006 Dec;4(12):1537-43

Institute of Clinical Pharmacology, University of Bern, Bern, and Department of Gastroenterology, University Hospital of Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2006.09.025DOI Listing
December 2006

Targets of emerging therapies for viral hepatitis B and C.

Expert Opin Ther Targets 2006 Dec;10(6):833-50

University of Bern, Clinic for Rheumatology and Clinical Immunology/Allergology, CH-3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14728222.10.6.83
Publisher Site
http://dx.doi.org/10.1517/14728222.10.6.833DOI Listing
December 2006

Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis.

J Hepatol 2006 Jun 3;44(6):1208-12. Epub 2006 Apr 3.

Department of Internal Medicine, Ospedale Civico, 6900 Lugano, Switzerland, and Women's College Health Sciences Centre, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2006.03.003DOI Listing
June 2006

Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report.

BMC Gastroenterol 2006 Mar 10;6:10. Epub 2006 Mar 10.

Gastroenterology and Hepatology, Ospedale Regionale, Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-230X-6-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421416PMC
March 2006

Evaluation of prescription practices of antibiotics in a medium-sized Swiss hospital.

Swiss Med Wkly 2005 Dec;135(47-48):710-4

Division of Infectious Disease, Department of Internal Medicine, Hospital Pharmacy, Ospedale Regionale di Lugano, Via Tesserete 46, CH-6903 Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/2005/47/smw-11174DOI Listing
December 2005

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.

Vaccine 2006 Apr 19;24(15):2781-9. Epub 2006 Jan 19.

Department of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2006.01.007DOI Listing
April 2006

Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins.

J Gen Virol 2005 Jun;86(Pt 6):1737-1746

Department of Medicine II, University of Freiburg, Hugstetter Str. 55, D-79106 Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/vir.0.80853-0DOI Listing
June 2005

Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.

Int Immunol 2005 Jun 20;17(6):695-704. Epub 2005 Apr 20.

Pevion Biotech Ltd, Rehhagstrasse 79, CH-3018 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxh249DOI Listing
June 2005

Hepatitis C virus and the immune system: a concise review.

Rev Med Virol 2005 Jul-Aug;15(4):235-68

Clinic for Rheumatology and Clinical Immunology/Allergology, University of Bern, CH-3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rmv.466DOI Listing
September 2005

[70-year-old patient with convulsive syncope].

Med Klin (Munich) 2004 Oct;99(10):626-9

Abteilung für Innere Medizin, Ospedale Regionale di Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00063-004-1093-7DOI Listing
October 2004

A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals.

Toxicology 2004 Apr;197(1):47-56

Division of Allergology, Clinic for Rheumatology and Clinical Immunology/Allergology, University of Bern, Inselspital, 3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tox.2003.12.008DOI Listing
April 2004

Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C.

Rev Med Virol 2003 Nov-Dec;13(6):361-71

Clinica Medica, Ospedale Civico, CH-6903 Lugano, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rmv.397DOI Listing
January 2004

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.

Int Immunol 2002 Jun;14(6):615-26

Clinic of Rheumatology and Clinical Immunology/Allergology, University Hospital, Inselspital, 3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxf026DOI Listing
June 2002

Viral crosstalk: who gets to say what first?

Authors:
Andreas Cerny

Hepatology 2002 Jun;35(6):1540-3

Clinica Medica, Ospedale Civico, Lugano, and Institute of Clinical Pharmacology, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.510350632DOI Listing
June 2002